Neutral
Business Wire
1 year ago
AGILE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Agile Therapeutics, Inc. - AGRX
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Agile Therapeutics, Inc. (OTC: AGRX) to Insud Pharma, S.L. Under the terms of the proposed transaction, shareholders of Agile will receive $1.52 in cash for each share of Agile that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the cons.